
Research
The mRNA Cancer Vaccine Breakthrough: What the 2026 Phase 3 Trial Reveals About Personalized Healing and God's Design
October 19, 2026
The first personalized mRNA cancer vaccine succeeded in a Phase 3 trial in 2026. Discover what the INTerpath-001 melanoma breakthrough reveals about the immune system God designed and what it means for whole-person healing.
Read more